Q2 · MEDICINE
Article
Author: Su, Jonathan T. ; Sung, Samuel ; Watrous, David ; Widanapathirana, Lakmini ; Karunakaran, Dipu ; Cain, Charlette M. ; Simpson, Solange M. ; Peet, M. Melissa ; Hope, Thomas ; Dobek, Georgina ; Qiu, Jiang ; Marzinke, Mark ; Tfaily, Ewa Bryndza ; Kiser, Patrick F. ; Pearson, Elizabeth ; Veazey, Ronald ; Grasperge, Brooke
We describe the
in vitro
and
in vivo
evaluation of a subcutaneous reservoir implant delivering tenofovir alafenamide hemifumarate (TAF) for the prevention of HIV infection. These long-acting reservoir implants were able to deliver antiretroviral drug for over 90 days
in vitro
and
in vivo
. We evaluated the implants for implantation site histopathology and pharmacokinetics in plasma and tissues for up to 12 weeks in New Zealand White rabbit and rhesus macaque models.